Pulmonary hypertension in chronic lung disease and hypoxia
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent of the underlying lung disease, which is best gauged through a combination of physiological and imaging assessment. Who, when, if and how to screen for PH will be addressed in this article, as will the current state of knowledge with regard to the role of treatment with pulmonary vasoactive agents. Although such therapy cannot be endorsed given the current state of findings, future studies in this area are strongly encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [294]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Self-citationSildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Consensus Statement on Chronic and Subacute High Altitude Diseases
León-Velarde, F., Maggiorini, M., Reeves, J. T., Aldashev, A., Asmus, I., Bernardi, L., Ge, R.-L., Hackett, P., Kobayashi, T., Moore, L. G., et al. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.147 · Cited by 630
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationKESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803117 · Cited by 549
Obesity-Associated hypoventilation in hospitalized patients: prevalence, effects, and outcome
Nowbar, S., Burkart, K. M., Gonzales, R., Fedorowicz, A., Gozansky, W. S., Gaudio, J. C., Taylor, M. R. G., & Zwillich, C. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.022 · Cited by 512
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
Cited by
Items 201–300 of 834
Munshi, R., Pellegrini, J. R., Patel, P., Kashin, M., Kang, J., Sexton, R., Russe-Russe, J. R., Makaryus, A. N., Patel, P., Thakkar, S. J., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211046838 · Cited by 18
Choudhury, P., Bhattacharya, A., Dasgupta, S., Ghosh, N., Senpupta, S., Joshi, M. V., Bhattacharyya, P., & Chaudhury, K. (2021) · Metabolomics · doi:10.1007/s11306-021-01845-9 · Cited by 18
Spatial Transcriptome Uncovers the Mouse Lung Architectures and Functions
Jiang, Y., Hao, S., Chen, X. X., Cheng, M., Xu, J., Li, C., Zheng, H., Volpe, G., Chen, A., Liao, S., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.858808 · Cited by 18
Quality of life in sarcoidosis
Moor, C. C., Obi, O. N., Kahlmann, V., Buschulte, K., & Wijsenbeek, M. S. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103123 · Cited by 17
Sakao, S., Tanabe, N., & Tatsumi, K. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013310 · Cited by 17
Cardiopulmonary Morbidity in Adults Born With Congenital Diaphragmatic Hernia
Kraemer, U., Kamphuis, L. S. J., Ciet, P., Visser, L., Tibboel, D., Bartelds, B., Otter, S. C. M. C.-D., de Blaauw, I., van Rosmalen, J., Gischler, S. J., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062341 · Cited by 17
Pulmonary Hypertension by the Method of Paul Wood
Newman, J. H. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.035 · Cited by 17
Sun, X., Meng, X., Zhang, P., Wang, L., Ren, Y., Xu, G., Yang, T., & Liu, M. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-160 · Cited by 17
Weatherald, J. C., Montani, D., & Humbert, M. J. C. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201901-0248ed · Cited by 17
Cajigas, H. R., Lavon, B. R., Harmsen, W. S., Muchmore, P., Costa, J., Mussche, C., Pulsipher, S., & Backer, J. D. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12321 · Cited by 16
Liu, Y., He, C., Zhong, Q., Shi, X., Li, H., Fu, G., Guo, L., Zhao, C., Tian, L., Li, X., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s493047 · Cited by 16
González-García, M., Rincón-Álvarez, E., Alberti, M. L., Durán, M., Caro, F. M., Venero, M. D. C., Liberato-Salinas, Y., & Buendía-Roldán, I. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.679487 · Cited by 16
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
Rajtík, T., Galis, P., Bartosova, L., Paulis, L., Gonçalvesová, E., & Klimas, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312800 · Cited by 16
Li, C., Zhu, H., Zhang, S., Meng, F., Li, S., Li, G., Zha, J., Wu, S., Zhu, L., & Dai, A. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154171 · Cited by 16
Klinger, J. R., Wu, B., Morland, K., Classi, P. M., Fiano, R., & Grabich, S. C. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107412 · Cited by 16
Persistent Nasal Inflammation 5 Months after Acute Anosmia in Patients with COVID-19
Hua-Huy, T., Lorut, C., Aubourg, F., Morbieu, C., Marey, J., Texereau, J., Fajac, I., Mouthon, L., Roche, N., & Dinh‐Xuan, A. T. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202011-4258le · Cited by 16
Developmental drugs for sarcoidosis
Obi, O. N., Saketkoo, L. A., Maier, L. A., & Baughman, R. P. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103179 · Cited by 15
Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future
Fiorentù, G., Bernardinello, N., Giulianelli, G., Cocconcelli, E., Balestro, E., & Spagnolo, P. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03129-3 · Cited by 15
Alhamad, E., Cal, J. G., Alrajhi, N. N., Paramasivam, M. P., Alharbi, W. M., Alessa, M., Omair, M. A., Al-Rikabi, A. R. D. A. C., & AlBoukai, A. (2021) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_632_20 · Cited by 15
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
van Genugten, E. A. J., Weijers, J. A. M., Heskamp, S., Kneilling, M., van den Heuvel, M. M., Piet, B., Bussink, J., Hendriks, L. E. L., & Aarntzen, E. H. J. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 14
Gialamas, I., Arvanitaki, A., Rosenkranz, S., Wort, S. J., Rådegran, G., Badagliacca, R., & Giannakoulas, G. A. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.04.066 · Cited by 14
Martin, R., Marek, N., Anna, L., Olivia, P., Bjermer, L. H., Westergren‐Thorsson, G., Tufvesson, E., & Larsson‐Callerfelt, A. (2024) · Respiratory Research · doi:10.1186/s12931-024-02907-x · Cited by 14
Louw, E. H., van Heerden, J. K., Kalla, I., Maarman, G. J., Nxumalo, Z., Thienemann, F., Huaman, M. A., Magee, M., & Allwood, B. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12424 · Cited by 14
Ahmad, S., Isbatan, A., Chen, S., Dudek, S. M., Minshall, R. D., & Chen, J. (2024) · Journal of Respiratory Biology and Translational Medicine · doi:10.70322/jrbtm.2024.10020 · Cited by 14
Shifting Paradigms in the Management of Pulmonary Hypertension
Pradhan, A. K., Tyagi, R., Sharma, P., Bajpai, J., & Kant, S. (2024) · European Cardiology Review · doi:10.15420/ecr.2024.11 · Cited by 14
Nathan, S. D., Stinchon, M. R., Atcheson, S., Simone, L., & Nelson, M. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.1-a.s2 · Cited by 14
Self-citationJCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis
Tamura, Y., Kusunose, K., Yamashita, Y., Akagi, T., Atsukawa, M., Fukumoto, Y., Goda, A., Goto, S., Hatano, M., Ikeda, M., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-1144 · Cited by 14
Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension
Rudyk, O., & Aaronson, P. I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63046-1_13 · Cited by 14
Bermudez, C. A., Crespo, M. M., Shlobin, O. A., Cantu, E., Mazurek, J. A., Levine, D. J., Gutsche, J. T., Kanwar, M. K., Dellgren, G., Bush, E. L., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.016 · Cited by 14
Lechartier, B., Chaouat, A., Aubert, J., & Schwitter, J. (2022) · Swiss Medical Weekly · doi:10.4414/smw.2022.w30055 · Cited by 14
Suraya, R., Nagano, T., Ryanto, G. R. T., Effendi, W. I., Hazama, D., Katsurada, N., Yamamoto, M., TACHIHARA, M. Y., Emoto, N., Nishimura, Y., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02081-y · Cited by 14
Sun, Y., Wu, W., Zhao, Q., Jiang, R., Li, J., Wang, L., Xia, S., Liu, M., Gong, S., Liu, J., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.967708 · Cited by 14
The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension
DuBrock, H. M., Reddy, Y. N. V., Durst, L. A., Schroeder, D. R., Park, G. S. H., Cajigas, H. R., Kane, G. C., Kushwaha, S. S., McCully, R. B., Murphy, J. G., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12143 · Cited by 14
Wang, C.-G., Liu, Y., Zhang, W., Zhang, M., Wang, Y., Huang, J.-A., Wang, R., Jiang, J.-H., & Zeng, D. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022178 · Cited by 14
Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis
Elnady, M. A., Elkorashy, R. I., Nabil, A., & Ibrahim, E. K. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02347-1 · Cited by 14
Non-invasive detection of severe PH in lung disease using magnetic resonance imaging
Alkhanfar, D., Dwivedi, K., Alandejani, F., Shahin, Y., Alabed, S., Johns, C., Garg, P., Thompson, A. A. R., Rothman, A. M. K., Hameed, A. G., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1016994 · Cited by 14
Pelaia, C., Armentaro, G., Lupia, C., Maiorano, A., Montenegro, N., Miceli, S., Condoleo, V., Cassano, V., Bruni, A., Garofalo, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175472 · Cited by 14
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.014 · Cited by 14
Bouchet, C., Cardouat, G., Douard, M., Coste, F., Robillard, P., Delcambre, F., Ducret, T., Quignard, J., Vacher, P., Baudrimont, I., et al. (2022) · Cells · doi:10.3390/cells11182795 · Cited by 14
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension
Santamans, A. M., Cicuéndez, B., Mora, A., Villalba‐Orero, M., Rajlic, S., Crespo, M., Vo, P., Jerome, M., Macías, Á., López, J. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk6524 · Cited by 13
Montani, D., Martínez, J. M. C., Rojo, R. P., Nunès, H., Meloni, F., Ghio, S., Cannon, J. E., Günther, A., García, H. G., Delgado, M. F., et al. (2024) · ERJ Open Research · doi:10.1183/23120541.00039-2024 · Cited by 13
COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study
Nathan, S. D., Lacasse, V., Bell, H., Sista, P. R., Marino, M. E. D., Bull, T., Tapson, V. F., & Waxman, A. B. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12430 · Cited by 13
Self-citationPulmonary arterial hypertension: guidelines and unmet clinical needs
Giuggioli, D., Bruni, C., Cacciapaglia, F., Dardi, F., Cata, A. D., Papa, N. D., Iannone, F., Lunardi, C., Maglione, W., Molinaro, F., et al. (2021) · Reumatismo · doi:10.4081/reumatismo.2020.1310 · Cited by 13
Santos‐Ribeiro, D., Lecocq, M., Beukelaer, M. D., Bouzin, C., Palmai‐Pallag, M., Yakoub, Y., Huaux, F., Horman, S., Perros, F., Pilette, C., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12177 · Cited by 13
Weiss, T., Near, A. M., Zhao, X., Ramey, D. R., Banerji, T., Xie, H., & Nathan, S. D. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02698-9 · Cited by 13
Self-citationClinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension
Mathijssen, H., Huitema, M. P., Bakker, A. L. M., Smits, F., Mager, J. J., Snijder, R. J., Grutters, J. C., & Post, M. C. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.03.279 · Cited by 13
Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease
Gonzales, J., & Fraidenburg, D. R. (2023) · Pharmaceuticals · doi:10.3390/ph16030418 · Cited by 12
Wang, J., Zhang, Y., Luo, Y., Liu, M. L., Niu, W., Li, Z. C., & Zhang, B. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08428-y · Cited by 12
Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial
Nathan, S. D., Rajicic, N., Dudenhofer, R. B., Hussain, R., Argula, R. G., Bandyopadhyay, D., Luckhardt, T., Muehlemann, N., Flaherty, K. R., Glassberg, M. K., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202406-662oc · Cited by 12
Self-citationGuenther, A., Tello, S., Schoppe, M. C., Pons‐Kühnemann, J., Seeger, W., Stiben, J., Tello, K., Molina‐Molina, M., Vancheri, C., Crestani, B., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207352 · Cited by 12
Self-citationMaarman, G. J. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00484.2021 · Cited by 12
Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosis
Muto, Y., Sekine, A., Hagiwara, E., Komatsu, S., Baba, T., Oda, T., Tabata, E., Sakayori, M., Fukui, K., Iwasawa, T., et al. (2022) · Respiratory Investigation · doi:10.1016/j.resinv.2022.02.005 · Cited by 12
Johnson, S. W., Finlay, L., Mathai, S. C., Goldstein, R. H., & Maron, B. A. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12126 · Cited by 12
Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?
Valentini, A., Franchi, P., Cicchetti, G., Messana, G., Chiffi, G., Strappa, C., Calandriello, L., del Ciello, A., Farchione, A., Preda, L., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13091607 · Cited by 12
Трушенко, Н. В., Suvorova, O., Nekludova, G. V., Levina, I. A., Chikina, S. Y., Nikolenko, A. M., Tsareva, N. A., Volkov, A. V., Yaroshetskiy, A. I., Мержоева, З. М., et al. (2023) · Life · doi:10.3390/life13061348 · Cited by 12
Gayen, S. K., Baughman, R. P., Nathan, S. D., Wells, A. U., Kouranos, V., Alhamad, E. H., Culver, D. A., Barney, J. B., Carmoma, E. M., CORDOVA, F. C., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12297 · Cited by 12
Self-citationBajwa, E. K., Cislak, D., Kumar, A., Li, D., Messina, E. J., Reynders, T., Denef, J., Vasile, C., Buch, K. P., Lai, E., et al. (2024) · International Journal of COPD · doi:10.2147/copd.s454905 · Cited by 12
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?
Blanco, I., Torres‐Castro, R., & Barberà, J. A. (2024) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001091 · Cited by 12
Wang, J., Lian, G., Luo, L., Wang, T., Xu, C., Wang, H., & Xie, L. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2020.101948 · Cited by 12
Pulmonary hypertension in eosinophilicversusnoneosinophilic COPD
Alzghoul, B. N., Sayaideh, M. A., Moreno, B. F., Singh, S. K., Innabi, A., Reddy, R. M., Papierniak, E. S., & Alnuaimat, H. (2021) · ERJ Open Research · doi:10.1183/23120541.00772-2020 · Cited by 12
Effect of sildenafil added to antifibrotic treatment in idiopathic pulmonary fibrosis
Kang, J., & Song, J. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-97396-z · Cited by 12
Xu, J., Wang, J.-J., Zhao, Q., Gong, S., Wu, W., Jiang, R., Luo, C., Qiu, H., Li, H., Wang, L., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003782 · Cited by 11
Rodriguez, D. A., Torres‐Castro, R., Piccari, L., García‐Ortega, A., Peñate, G. M. P., de Miguel‐Díez, J., Rojo, R. P., Pumarega, I. C., Cuesta, V. M. M., Blanco, I., et al. (2025) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2025.03.015 · Cited by 11
Marshall, W. H., V, Gee, S. E., Lim, W., Lastinger, L. T., Cackovic, M., Benza, R. L., Daniels, C. J., Bradley, E. A., & Rajpal, S. (2022) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2022.100354 · Cited by 11
Huang, W., Hsieh, S., Wu, Y., Hsieh, T., Wu, Y., Li, K., Charng, M., Chen, W., Sung, S., Tsao, Y., et al. (2023) · PubMed Central · doi:10.6515/acs.202303_39(2).20230117a · Cited by 11
Hpgd affects the progression of hypoxic pulmonary hypertension by regulating vascular remodeling
He, M., Tao, K., Xiang, M., & Sun, J. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02401-y · Cited by 11
Okaya, T., Kawasaki, T., Sato, S., Koyanagi, Y., Tatsumi, K., Hatano, R., Ohnuma, K., Morimoto, C., Kasuya, Y., Hasegawa, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020748 · Cited by 11
Gillmeyer, K. R., Rinne, S. T., Glickman, M. E., Lee, K. M., Shao, Q., Qian, S. X., Klings, E. S., Maron, B. A., Hanlon, J. T., Miller, D. R., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005993 · Cited by 11
Clinical trials in group 3 pulmonary hypertension
Harder, E. M., & Waxman, A. B. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000694 · Cited by 11
Kato, M., Sugimoto, A., & Atsumi, T. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1825940 · Cited by 11
Yang, Y., Yuan, H., Liu, X., Wang, Z., Li, Y., Ren, Y., Gao, C., Jiao, T., Cai, Y., & Zhao, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.812411 · Cited by 11
Blanco, I., Valeiro, B., Torres‐Castro, R., Barberán-García, A., Torralba, Y., Moisés, J., Sebastián, L., Osorio, J., Ríos, J., Gimeno‐Santos, E., et al. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.10.018 · Cited by 11
González-García, M., Aguirre-Franco, C., Vargas-Ramírez, L., Barrero, M., & Torres-Duque, C. A. (2022) · Chronic Respiratory Disease · doi:10.1177/14799731221104095 · Cited by 11
Wang, J., Wang, L., Chen, X., Liang, M.-L., Wei, D.-H., Cao, W., & Zhang, J. (2022) · PubMed Central · doi:10.22038/ijbms.2022.64170.14133 · Cited by 11
Gillmeyer, K. R., Miller, D. R., Glickman, M. E., Qian, S. X., Klings, E. S., Maron, B. A., Hanlon, J. T., Rinne, S. T., & Wiener, R. S. (2021) · Pulmonary Circulation · doi:10.1177/20458940211001714 · Cited by 11
Zeder, K., Sassmann, T., Foris, V., Douschan, P., Olschewski, H., & Kovács, G. (2024) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2024.100519 · Cited by 10
Self-citationTreatment of pulmonary hypertension after seven world symposia
Estrada, R. A., Sahay, S., & Tonelli, A. R. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251342898 · Cited by 10
Pulmonary Hypertension Associated With Interstitial Lung Diseases
Jose, A., Sood, N., Elwing, J., Akkanti, B. H., Bajwa, A. A., Bernardo, R. J., Estrada, R. A., Sharma, M., Soto, F. J., Tonelli, A. R., et al. (2025) · CHEST Journal · doi:10.1016/j.chest.2025.07.4107 · Cited by 10
Wang, X., Deng, T., Zhu, H., Peng, J., Liang, J., Zhong, S., Chen, Y., & Jin, G. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s531109 · Cited by 10
Endothelial ADAR1 Deficit Induces the NOCT-IRF7 Axis in Pulmonary Hypertension
Woodcock, C.-S. C., Maroli, G., Kim, H., Tai, Y., Tang, Y. M., Okawa, S., Homsi, R., Kim, Y., Cho, S., Jiang, S., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326277 · Cited by 10
Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review
Raghu, G., Sahay, S., Price, L. C., Weatherald, J. C., Rayner, S. G., Behr, J., Boucly, A., Das, M., McLaughlin, V., Rahaghi, F., et al. (2026) · European Respiratory Journal · doi:10.1183/13993003.02651-2025 · Cited by 10
Riou, M., Canuet, M., Ghigna, M., Eyries, M., Chenard, M. P., Porzio, M., Olland, A., Humbert, M. J. C., Kessler, R., & Montani, D. (2022) · European Respiratory Journal · doi:10.1183/13993003.01197-2022 · Cited by 10
A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
Vahdatpour, C., Epstein, S., Jones, K., Smoot, M., Parker, A., Ryan, J. J., & Bryant, A. J. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100255 · Cited by 10
Pulmonary vascular stenosis scoring in fibrosing mediastinitis
Wang, Y., Bu, C., Zhang, M., Wang, J., Jiang, K., Ding, M., Su, H., Long, X., Jia, M., Li, Y., et al. (2024) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyae034 · Cited by 10
Diagnosis and Management of Pulmonary Hypertension: New Insights
Ntiloudi, D., Kasinos, N., Kalesi, A. E., Vagenakis, G. A., Theodosis-Georgilas, A., & Rammos, S. (2024) · Diagnostics · doi:10.3390/diagnostics14182052 · Cited by 10
Bačáková, L., Sedlář, A., Musílková, J., Eckhardt, A., Žaloudíková, M., Kolář, F., & Maxová, H. (2024) · Physiological Research · doi:10.33549/physiolres.935394 · Cited by 10
Nagai, A., Sagawa, K., Tsujioka, T., Fujimoto, T., Taniguchi, K., Sasaki, O., Izumi, G., Yamazawa, H., Masaki, N., Manabe, A., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01604-1 · Cited by 10
Demographics and Outcomes of Pulmonary Hypertension Patients in United States Emergency Departments
Wilcox, S. R., Faridi, M. K., & Camargo, C. A. (2020) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.2.45187 · Cited by 10
Farmakis, I. T., Vazakidis, P., Doundoulakis, I., Arvanitaki, A., Zafeiropoulos, S., Boutou, A., Karvounis, H. I., & Giannakoulas, G. A. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102036 · Cited by 10
Fan, F., Zou, Y., Wang, Y., Zhang, P., Wang, X., Dart, A. M., & Zou, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768513 · Cited by 10
Hill, M., Jörgensen, S., Engström, G., Persson, M., Wollmer, P., & Lexell, J. E. (2022) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2022.2031478 · Cited by 10
Saleh, K. M. M., Khan, N., Dougherty, K., Bodi, G., Michalickova, M., Mohammed, S., Kerenidi, T., Sadik, Z. G., Mallat, J., Farha, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051996 · Cited by 10
Piccari, L., Colindres, R. J. A., & Rodriguez, D. A. (2023) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000984 · Cited by 10
Jutant, E., Montani, D., Sattler, C., Günther, S., Sitbon, O., Garcia, G., Arnulf, I., Humbert, M. J. C., Similowski, T., & Redolfi, S. (2021) · Pulmonary Circulation · doi:10.1177/2045894021996930 · Cited by 10
Saggar, R., Giri, P. C., Deng, C., Johnson, D., McCloy, M. K., Liang, L. L., Shaikh, F. M., Hong, J. S., Channick, R. N., Shapiro, S., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211011329 · Cited by 10
Hypersensitivity Pneumonitis With and Without Autoimmune Features: A Clinical Comparative Analysis
Kalra, S. S., Jaber, J. F., Alzghoul, B. N., Jansen, B., Innabi, A., Tran, A. B., Fu, K., Reddy, R. M., Manjarres, D. C. G., & Patel, D. C. (2022) · Lung · doi:10.1007/s00408-022-00577-4 · Cited by 10
Pulmonary hypertension associated with COPD: a phenotype analysis
Steger, M., Canuet, M., Martin, G., Labani, A., Schwartz, J. C., Enache, I., Schuller, A., Meyer, L., Chaouat, A., Kessler, R., et al. (2024) · ERJ Open Research · doi:10.1183/23120541.00716-2024 · Cited by 9
Kattih, Z., Kim, H. C., Aryal, S., & Nathan, S. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062029 · Cited by 9
Self-citationLi, R., Liu, S., Wang, X., Wang, R., & Linning, E. (2025) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-1770 · Cited by 9
Gayen, S. K., Zulty, M., & Criner, G. J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02674-9 · Cited by 9
Metadata
- Authors
- Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., Weissmann, N., & Seeger, W.
- Affiliations
- Inova Fairfax Hospital (US)
- MultiMedica (IT)
- Medical University of Graz (AT)
- Medizinische Hochschule Hannover (DE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Justus-Liebig-Universität Gießen (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801914
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351338
- OpenAlex
- W2904463477
- Cited by
- 757
- References
- 94
- Citations by year
- 2026: 54 · 2025: 104 · 2024: 141 · 2023: 96 · 2022: 122 · 2021: 114 · 2020: 76 · 2019: 44
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- American Thoracic Society
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- United Therapeutics Corporation
- Sunovion
- Veracyte
- York University
- National Institutes of Health
- Genentech
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic lung disease, hypoxia, hemodynamic assessment, quality of life, mortality risk, oxygen requirement
- MeSH terms
- Animals, Hypoxia, Antihypertensive Agents, Chronic Disease, Humans, Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.